Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

Trastuzumab Deruxtecan 5.4, Breast Cancer

Protocol-ID: 1634 V1.0 (Mini), TRASDE5.4, Breast Ca

Indication(s)

  • Breast Cancer (HER2+, HER2-low); ICD-10 C50.-

Links

  • Trastuzumab-Deruxtecan [EMA EPAR]
  • ENHERTU (fam-trastuzumab deruxtecan-nxki) for injection, for intravenous use
 [URL]
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti.

Valid since: 10.09.2020